2015 Lipper Award

Janus Contrarian Fund (JSVAX)

Investing Opportunistically in Non-Consensus Equity Ideas

SHARE CLASS

FUND FACTS (JSVAX)

Inception Date2/29/2000
NAV (As of 8/3/15 )$20.88
Total Net Assets (As of 6/30/15)$3.92B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.89%
NET 0.89%

Performance (As of 6/30/15)
1 Year-0.50%
3 Year19.05%
5 Year13.10%
10 Year8.13%
Morningstar (As of 6/30/15)
CategoryLarge Blend
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Net expense ratios reflect the expense waiver, if any, Janus Capital has contractually agreed to through 2/1/16.

Data as of 6/30/15. Index represents the S&P 500® Index.

TOP HOLDINGS (% of Fund)

United Continental Holdings Inc 9.58
Endo International PLC 8.54
Mallinckrodt PLC 7.52
Air Products & Chemicals Inc 5.18
Motorola Solutions Inc 4.90
St Joe Co 4.14
Knowles Corp 4.11
Mattel Inc 3.92
Dollar Tree Inc 3.69
E*TRADE Financial Corp 3.26
TOTAL54.84

CHARACTERISTICS

Number of Holdings
Equity Issues

40
Market Capitalization
Weighted Average
Median

$32.95B
$13.76B
Portfolio Turnover Ratio
(1-year trailing)

67.20%
Price/Earnings Ratio
(1-year forward)

17.88
Price/Book Ratio
(1-year forward)

3.38
Earnings Growth Rate
(1-year forward)

9.80%

MONTHLY TOP EQUITY
CONTRIBUTORS & DETRACTORS

CONTRIBUTORS
Dollar Tree Inc
Herbalife Ltd
JPMorgan Chase & Co
E*TRADE Financial Corp
Advance Auto Parts Inc
DETRACTORS
Mallinckrodt PLC
Endo International PLC
MarkWest Energy Partners LP
Lands' End Inc
Air Products & Chemicals Inc

SECTOR ALLOCATION (%)

FUND INDEX 
Health Care 17.84 15.44
 
 
Consumer Discretionary 16.12 12.77
 
 
Industrials 16.04 10.08
 
 
Financials 15.43 16.52
 
 
Information Technology 12.25 19.70
 
 
Materials 11.29 3.13
 
 
Energy 5.05 7.87
 
 
Consumer Staples 3.63 9.39
 
 
Equity Other -1.01 -
Cash & Equivalents 2.31 -
 
Restricted Cash 1.05 -
 

DEVELOPED VS. EMERGING MARKET EXPOSURE (%)

FUNDINDEX
U.S. 92.96 99.97
Non-U.S. Emerging 1.91 -
Non-U.S. Developed 1.77 0.03
Restricted Cash 1.05 -
Cash & Equivalents 2.31 -

REGIONS (%)

FUNDINDEX
North America 92.96 99.97
Asia/Pacific Ex Japan 1.91 -
Europe 1.77 0.03
Cash & Equivalents 2.31 -
Restricted Cash 1.05 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS (%)

FUNDINDEX
Over $100 Billion 8.52 42.97
$10 Billion to $50 Billion 51.71 33.80
$5 Billion to $10 Billion 21.34 3.90
$1 Billion to $5 Billion 13.55 0.38
$500 Million to $1 Billion 2.05 -
N/A -0.53 -

Equity country, regional, sector and industry weights based on MSCI and GICS classifications. Fixed income country, regional, sector and industry weights based on Barclays classifications.